Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disease of Liver and Bile Duct”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00007020
What this trial is testing

Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid

Who this might be right for
Infantile Refsum's DiseaseZellweger SyndromeAdrenoleukodystrophy+2 more
Mirum Pharmaceuticals, Inc. 85
Not applicableStudy completedNCT02477462
What this trial is testing

Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients

Who this might be right for
Primary Biliary Cirrhosis
University of California, Davis 124
Testing effectiveness (Phase 2)UnknownNCT02193360
What this trial is testing

Pilot Study of FFP104 Dose Escalation in PBC Subjects

Who this might be right for
Primary Biliary Cirrhosis
Fast Forward Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT04604652
What this trial is testing

Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis

Who this might be right for
Primary Biliary CholangitisPrimary Biliary CirrhosisCholangitis+3 more
HighTide Therapeutics (Hong Kong) Limited 24
Not applicableWithdrawnNCT05293938
What this trial is testing

A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

Who this might be right for
Primary Biliary Cholangitis
Intercept Pharmaceuticals
Not applicableStudy completedNCT02659696
What this trial is testing

Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis

Who this might be right for
Primary Biliary Cirrhosis
Teikyo University 44
Testing effectiveness (Phase 2)Study completedNCT00033462
What this trial is testing

Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+8 more
National Cancer Institute (NCI) 78
Not applicableLooking for participantsNCT07335523
What this trial is testing

Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation

Who this might be right for
Exocrine Pancreatic Insuficiency
Digestive Care, Inc. 30
Not applicableUnknownNCT04260503
What this trial is testing

Gut Microbiome in Biliary Atresia

Who this might be right for
Biliary Atresia
Yonsei University 36
Early research (Phase 1)Study completedNCT06798454
What this trial is testing

Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC)

Who this might be right for
Primary Biliary Cholangitis (PBC)
Parvus Therapeutics, Inc. 24
Not applicableStudy completedNCT06686810
What this trial is testing

Endoscopy and Primary Sclerosing Cholangitis

Who this might be right for
Primary Sclerosing Cholangitis (PSC)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 118
Testing effectiveness (Phase 2)WithdrawnNCT01859182
What this trial is testing

Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the GallbladderAdult Primary Cholangiocellular Carcinoma+12 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Active Not RecruitingNCT04167358
What this trial is testing

Linerixibat Long-term Safety, and Tolerability Study

Who this might be right for
Cholestasis
GlaxoSmithKline 242
Testing effectiveness (Phase 2)Study completedNCT01425879
What this trial is testing

MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver Carcinoma+5 more
National Cancer Institute (NCI) 8
Not applicableNot Yet RecruitingNCT07122206
What this trial is testing

Monitoring the Response of Combination Ursodiol and Seladelpar Treatment

Who this might be right for
Primary Biliary Cholangitis
Methodist Health System 100
Not applicableLooking for participantsNCT06675604
What this trial is testing

LEOPARD Training and Validation Data Collection Study

Who this might be right for
Decompensated Liver CirrhosisPrimary Biliary CholangitisPrimary Sclerosing Cholangitis+1 more
Assistance Publique - Hôpitaux de Paris 4,500
Not applicableStudy completedNCT03941184
What this trial is testing

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

Who this might be right for
SCADAddison DiseaseAnkylosing Spondylitis+26 more
Mayo Clinic 114
Not applicableActive Not RecruitingNCT04785534
What this trial is testing

Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis

Who this might be right for
Liver and Intrahepatic Bile Duct Carcinoma
M.D. Anderson Cancer Center 1,000
Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Large-scale testing (Phase 3)Study completedNCT06060665
What this trial is testing

Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)

Who this might be right for
Primary Biliary Cholangitis
Gilead Sciences 96
Next Page